韩国脓毒症发病率、结局及死亡风险因素:全国性队列研究
该回顾性全国队列研究利用韩国国民健康保险服务数据库(2011–2022年),纳入18岁及以上因脓毒症住院的成人患者,共识别1,149,379例脓毒症病例。粗发病率从141.8/10万人年升至337.3/10万人年,年龄标化发病率增加53.1%;院内死亡率从27.0%降至17.0%,但总死亡数从15,605例增至25,326例。多因素分析显示年龄较大、男性、更高合并症负担和更高疾病严重度为死亡的独立风险因素;医疗援助受益者和农村居民死亡率更高,三级医院治疗与结局改善相关。
要点
- 2011–2022年韩国脓毒症粗发病率由141.8升至337.3/10万人年,年龄标化发病率增加53.1%,发病率上升趋势显著。
- 院内死亡率从27.0%降至17.0%,线性回归β=-1.1%/年(p<0.001,R2=0.91),但总死亡数从15,605例增至25,326例。
- 多因素分析:年龄较大、男性、更高合并症负担和更高疾病严重度为院内死亡的独立风险因素。
- 社会经济差异:医疗援助受益者和农村居民死亡率更高,三级医院治疗与结局改善相关。
- 作者提醒:发病率与死亡率趋势需谨慎解读,因病例识别实践可能存在变化。
适用人群与场景
- 韩国2011–2022年全国18岁及以上因脓毒症住院的成人患者,使用ICD-10编码从国民健康保险服务数据库识别。
- 数据来源为全国理赔数据库,涵盖韩国医疗体系,非急诊/ICU特定人群。
诊断标准与关键阈值
- 脓毒症病例通过国际疾病分类第10版(ICD-10)编码识别,原文未提供具体编码或临床诊断标准。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性、基于人群的队列研究;数据来源:韩国国民健康保险服务数据库;研究期间:2011–2022年;样本量:1,149,379例脓毒症病例。
- 粗发病率从141.8升至337.3/10万人年;年龄标化发病率增加53.1%;Poisson回归:粗发病率IRR=1.09(95%CI 1.08–1.09,p<0.001),年龄标化发病率IRR=1.04(95%CI 1.04–1.04,p<0.001)。
- 院内死亡率从27.0%降至17.0%(β=-1.1%,p<0.001,R2=0.91);总死亡数从15,605例增至25,326例(β=779,p<0.001,R2=0.98)。
- 多因素logistic回归:年龄较大、男性、更高合并症负担、更高疾病严重度为院内死亡的独立风险因素。
- 医疗援助受益者和农村居民死亡率更高;三级医院治疗与结局改善相关。
证据类型、等级与局限
- 证据类型:回顾性、基于人群的全国性队列研究(基于理赔数据库)。
- 局限:作者指出因病例识别实践可能变化,趋势需谨慎解读;原文未提及其他局限。
对床旁实践的改变
- 该研究提示脓毒症总体负担增加(总死亡数上升),即使院内死亡率下降,急诊/ICU仍需关注老龄化、合并症负担高和疾病严重度高患者的死亡风险。
- 识别到医疗援助受益者和农村居民死亡率更高,提示需关注社会经济弱势群体的救治可及性与支持。
- 三级医院治疗与结局改善相关,但原文未提供具体干预措施,不能据此改变具体临床处置。
- 原文未提供可直接用于床旁决策的阈值、药物剂量或流程推荐。
指南或共识出处
- 原文未提及指南或共识;来源为Crit Care Med发表的原始研究。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine contemporary nationwide trends in sepsis incidence and mortality in South Korea and the associated clinical and socioeconomic factors.
DESIGN: Retrospective, population-based cohort study.
SETTING: Korea's healthcare system from 2011 to 2022, utilizing the National Health Insurance Service database.
PATIENTS: Adult patients 18 years old or older hospitalized for sepsis and identified using the International Classification of Diseases, 10th Revision codes.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Incidence and mortality were analyzed annually over the study period. Poisson and linear regression models were used to analyze temporal trends in sepsis incidence and mortality. Multivariable logistic regression was performed to evaluate risk factors for in-hospital mortality. In all, 1,149,379 sepsis cases were identified. The crude incidence of sepsis increased from 141.8 to 337.3 per 100,000 person-years from 2011 to 2022, whereas the age-standardized incidence increased by 53.1%. In-hospital mortality decreased from 27.0% to 17.0%. Poisson regression analysis showed significant increases in crude and age-standardized incidence (incidence rate ratio [IRR], 1.09; 95% CI, 1.08-1.09; p < 0.001 and IRR, 1.04; 95% CI, 1.04-1.04; p < 0.001, respectively). In-hospital mortality consistently declined from 27.0% in 2011 to 17.0% in 2022 (β = -1.1%; p < 0.001; R2 = 0.91). However, the total number of deaths increased from 15,605 in 2011 to 25,326 in 2022 (β = 779; p < 0.001; R2 = 0.98). Multivariable analysis identified that older age, male sex, higher comorbidity burden, and greater disease severity were independent risk factors for mortality. Socioeconomic disparities were evident: medical aid beneficiaries and rural residents had higher mortality, whereas treatment at tertiary hospitals was associated with improved outcomes.
CONCLUSIONS: In this nationwide claims-based study, recorded sepsis incidence increased and in-hospital mortality declined over time, although these trends warrant cautious interpretation given potential shifts in case identification practices. Socioeconomic disparities in mortality persisted throughout the study period.
参考来源
- Lee D, Lee Y, Kim J, et al. Incidence, Outcomes, and Risk Factors for Mortality in Patients With Sepsis in South Korea: A Nationwide Cohort Study. Crit Care Med. 2026. PMID: 42606299. doi:10.1097/CCM.0000000000007306
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。